Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth S. Kornman currently holds 400,065 shares of INTERLEUKIN GENETICS INC (ILI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth S. Kornman has been a net buyer of ILI stock. They have purchased $7.0K and sold $0 worth of shares.
Kenneth S. Kornman's most recent insider trade was on Jul 29, 2016, when they purchased 25,150 shares at $0.10 per share.
Kenneth S. Kornman serves as Executive at INTERLEUKIN GENETICS INC (ILI). They have executed 13 insider transactions totaling $7.0K over their tenure at the company.
Kenneth S. Kornman holds the position of Executive at INTERLEUKIN GENETICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kenneth S. Kornman has shown a buying trading pattern, with $7.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kenneth S. Kornman was on Mar 31, 2007, when they purchased $54.8K worth of ILI shares. This transaction involved 12,500 shares at $4.38 per share.
Kenneth S. Kornman currently owns 400,065 shares of INTERLEUKIN GENETICS INC (ILI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth S. Kornman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth S. Kornman has 13 Form 4 filings on record as an insider at INTERLEUKIN GENETICS INC.
Set alerts for Kenneth S. Kornman and 40,000+ other insiders.